Your browser doesn't support javascript.
loading
Insidious Insights: Implications of viral vector engineering for pathogen enhancement.
Sandbrink, Jonas B; Alley, Ethan C; Watson, Matthew C; Koblentz, Gregory D; Esvelt, Kevin M.
Afiliação
  • Sandbrink JB; Nuffield Department of Medicine, University of Oxford, Oxford, UK. jonas.sandbrink@trinity.ox.ac.uk.
  • Alley EC; Future of Humanity Institute, University of Oxford, Oxford, UK. jonas.sandbrink@trinity.ox.ac.uk.
  • Watson MC; Media Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Koblentz GD; Center for Health Security, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Esvelt KM; Schar School of Policy and Government, George Mason University, Fairfax, VA, USA.
Gene Ther ; 30(5): 407-410, 2023 05.
Article em En | MEDLINE | ID: mdl-35264741
ABSTRACT
Optimizing viral vectors and their properties will be important for improving the effectiveness and safety of clinical gene therapy. However, such research may generate dual-use insights relevant to the enhancement of pandemic pathogens. In particular, reliable and generalizable methods of immune evasion could increase viral fitness sufficient to cause a new pandemic. High potential for misuse is associated with (1) the development of universal genetic elements for immune modulation, (2) specific insights on capsid engineering for antibody evasion applicable to viruses with pandemic potential, and (3) the development of computational methods to inform capsid engineering. These risks may be mitigated by prioritizing non-viral delivery systems, pharmacological immune modulation methods, non-genetic vector surface modifications, and engineering methods specific to AAV and other viruses incapable of unassisted human-to-human transmission. We recommend that computational vector engineering and the publication of associated code and data be limited to AAV until a technical solution for preventing malicious access to viral engineering tools has been established.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas do Capsídeo / Vetores Genéticos Limite: Humans Idioma: En Revista: Gene Ther Assunto da revista: GENETICA MEDICA / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas do Capsídeo / Vetores Genéticos Limite: Humans Idioma: En Revista: Gene Ther Assunto da revista: GENETICA MEDICA / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido